Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValereum Plc Regulatory News (VLRM.PL)

Share Price Information for Valereum Plc (VLRM.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.27    -0.06 (-2.58%)
Bid:
2.24
Ask:
2.30
Spread: 0.06 (2.679%)
Market Cap: £12.31m
VLRM.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Valereum Plc Share Chart

Agreed Subscription to Raise £2 million

31 May 2024 15:02

RNS Number : 7080Q
Valereum PLC
31 May 2024
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")

 

31/05/2024

Valereum Plc("Valereum" or the "Company")

Agreed Subscription to Raise £2 million

Directors' Dealing

Valereum plc (AQSE: VLRM) is pleased to announce it has reached a new agreement to raise £2 million from its Chairman, James Formolli, through the issuance of 55,411,752 new ordinary shares of £0.001 each in the capital of the Company (the "Subscription Shares") at £0.036 per Subscription Share (the "Subscription Price") with no warrants attached (the "Subscription"). In place of issuing warrants, VLRM will attach 15,000,000 GATE Tokens, VLRM's utility token. The Subscription Price represents a discount of approximately 13% to the mid-market price of £0.04125 per share as at the time of entering into the agreement.

This announcement supersedes the previous announcement made on the 20th February 2024 whereby it was announced that the Company had received a firm commitment towards initial funding of £2,500,000 (of which £300,000 has already been received as per the announcement made on 28 March 2024) at £0.06 per Ordinary Share from Valereum's Chairman, James Formolli, consisting of 41,666,666 ordinary shares being issued at £0.06 (of which 5,000,000 have been issued) and 41,666,666 warrants issued at £0.001 (of which 5,000,000 have been issued) with a lock-in period of 12 months; hence, significantly reducing shareholder dilution. The Subscription is expected to complete in the week commencing 1 July 2024 and it is unconditional.

A further announcement, including information on the new total voting rights, will be made in due course when the Subscription is completed.

The proceeds of the raise will be used to fund Valereum's growth across its VLRM Markets, Technology and Capital verticals. In addition, the proceeds will be used to expand the utility of GATE Token across the VLRM ecosystem. 

More specifically, the funding enables the strategic delivery of our shared roadmap, including developing the DFMI Bridge technology infrastructure; supporting the development of VLRM marketplace operations, including licensing applications and technology deployment; It will also allow the funding of VRLM Capital's fund structures and support the integration and expansion of GATE tokens utility and liquidity. This will be communicated to the markets over the coming weeks.

Valereum remains committed to executing these strategic initiatives to drive growth and value for its shareholders.

On completion of the Subscription, James Formolli's shareholding is expected to increase to 40.12%.

Rule 4.6 Statement - Related Party Transaction

In relation to James Formolli's investment commitment and terms, the directors (other than James Formolli) confirm that, having exercised reasonable care, skill and diligence, the related party transaction is fair and reasonable as far as the shareholders of the issuer are concerned.

James Formolli, Executive Chairman of Valereum, commented:

"I remain fully committed to supporting my team and am delighted to provide investment at a higher valuation than previously indicated. I strongly believe in Valereum's vision and technology, and as a part of my investment, I look forward to developing and enhancing our current Gate Token utility across VLRM's ecosystem. There are enormous opportunities to align the interests of VLRM shareholders, customers and GATE Token holders through a number of future initiatives.

Nick Cowan, CEO of Valereum, commented:

"This revised capital raise shows great commitment and belief from our Chairman and supports VLRM's growth path across all of its activities. As a team, we firmly believe in the significant opportunity created through tokenisation over the next decade, and as a technology solutions provider and an operator of tokenised marketplaces, we aim to create value for all stakeholders."

For further information, please contact:

Enquiries:

Valereum Plc

James Formolli, Chairman

Tel: +971 4584 6284

 

Stanford Capital Partners

Tel: 023 3650 3650

Bob Pountney

Patrick Claridge

 

AQSE Corporate Adviser

First Sentinel Corporate Finance

Brian Stockbridge

Tel: +44 20 3855 5551

 

Further updates to follow in due course.

 

The directors of the Company accept responsibility for the contents of this announcement.

 

For more information, please visit the Company's website at www.vlrm.com

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES OR CONNECTED PERSONS

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Formolli

2.

Reason for the Notification

a)

Position/status

Chairman

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Valereum Plc

b)

LEI

213800EJ8BFEQQ9POX79

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A1171Y8

b)

Nature of the transaction

Agreement to subscribe for shares, with completion to take place in the w/c 1 July 2024.

c)

Price(s) and volume(s)

 

Price

Volume

£0.036 per Ordinary Share

55,411,752 Ordinary Shares

d)

Aggregated information:

· Aggregated volume

· Price

 

Single transaction, see details in item (c) above

e)

Date of the transaction

31 May 2024

f)

Place of the Transaction

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXUARSRSAUVOAR
Date   Source Headline
5th Jun 20264:32 pmRNS-RValereum Vox Issue 4 Published
1st Jun 20267:00 amRNSHolding(s) in Company
22nd May 20263:00 pmRNS-RValereum Vox Issue 3 Published
15th May 20267:00 amRNSPlacing and Subscription Raising £1,050,000
11th May 20264:10 pmRNS-RValereum Vox Issue 2 Published
23rd Apr 20261:45 pmRNS-RLaunch of new blog, Valereum Vox
22nd Apr 20267:00 amRNSDefinitive Agreement with QGP
21st Apr 20267:00 amRNSSettlement Agreement with Blubird
16th Apr 20267:00 amRNSDefinitive Agreement Update
10th Apr 20262:48 pmRNSReplacement - Coupon Payment Received
10th Apr 20262:07 pmRNSCoupon Payment Received
9th Apr 202611:32 amRNSShare Options and PDMR Dealings
31st Mar 20261:46 pmRNSInvestor Meeting
31st Mar 20267:31 amRNSProposed Strategic Integration and Coupon Payment
4th Mar 20267:00 amRNSOTCQB Approval
27th Feb 202610:53 amRNSVLRM Markets Organisational Update
25th Feb 20267:00 amRNSOption Agreement to Cancel 2 Million Warrants
16th Feb 20267:00 amRNSDirectorate Changes
16th Feb 20267:00 amRNSSigning of MoU with Integra Foundation
9th Feb 20267:00 amRNSSigning of MoU with RWA.io & Defactor
6th Feb 20267:00 amRNSChanges to Board of Directors
30th Jan 20262:00 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSSigning of MoU and Exercise of Warrants
27th Jan 20263:50 pmRNSHolding(s) in Company
26th Jan 20267:00 amRNSForward Strategy Update
21st Jan 20267:00 amRNSAgreement and Lifting of Suspension
22nd Dec 20257:00 amRNSContract
22nd Dec 20257:00 amRNSContract
17th Dec 20257:00 amRNSResignation of Corporate Adviser and Suspension
4th Dec 202510:56 amRNS-ROTC Application
2nd Dec 202510:34 amRNSUpdate on Capital Raise
25th Nov 20257:00 amRNSAgreement to Raise Capital
21st Nov 20257:00 amRNSExercise of Warrants
17th Nov 20257:00 amRNSCompletion of Subscription
14th Nov 20257:00 amRNSDeployment of DigiShares’ Tokenisation Platform
27th Oct 20257:00 amRNS-RCOINGT to List on VLRM Markets
10th Oct 20257:00 amRNSSubscription to Raise £600,000
7th Oct 20257:00 amRNSVLRM Markets’ Post Launch Update
1st Oct 20259:00 amRNSOption Agreement to Cancel 2m Warrants
25th Sep 20257:00 amRNSValereum Advances GATE Token Strategy
24th Sep 20254:47 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSInterim Results
19th Sep 20257:00 amRNS-RUpdate on Strategy Implementation
10th Sep 20257:00 amRNS-RVLRM to Co-host Exclusive Side Event at TOKEN2049
4th Sep 20257:00 amRNS-RCrypto and Multi Currency Payroll Solution
20th Aug 20251:00 pmRNS-RStrategic Collaboration with ZIGChain & DigiShares
18th Aug 20257:00 amRNS-RIndirect Investee Update
14th Aug 20257:00 amRNSResult of WRAP Retail Offer
11th Aug 20254:30 pmRNSWRAP Retail Offer for up to £100,000
11th Aug 20257:00 amRNSStrategic Investment in Metrikus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.